Tnkase Kit
Product Images NDC 50242-120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tnkase (NDC 50242-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B-d (1a9e312c F0b0 4139 B526 B904b80883a4 01)

TNKase vial label from Genentech, Inc. showing the product name prominently. The label includes dosing and usage instructions in a block of text, along with regulatory and identification numbers and barcodes. The design uses a white background with burgundy and black text.*

FDA Label Image

Dual Cannula Device (1a9e312c F0b0 4139 B526 B904b80883a4 02)

An instructional diagram showing components of a syringe assembly for TNKase, including a 10 mL syringe, red hub cannula syringe filling device, Twinpak™ shield, blunt plastic cannula, and green cap, arranged in sequence from left to right.*

FDA Label Image

Principal Display Panel (Kit Carton)

Label for TNKase 50 mg vial by Genentech, Inc. The vial contains Tenecteplase 50 mg for use in myocardial infarction. The kit includes one 50 mg vial of TNKase, 10 mL vial of preservative-free Sterile Water for Injection, a 10 mL syringe with TwinPak Dual Cannula Device, and a package insert. The vial contents and US license number 1048 are also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.